Gensaic Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

Gensaic General Information

Description

Developer of a machine-guided protein design platform designed to create tissue-selective, intracellular therapies for metabolic and age-related diseases. The company offers a DNA-barcoded protein evolution engine that combines large-scale in vivo screening with predictive protein modeling, enabling patients with muscle-wasting and obesity to benefit from precisely delivered, dual-targeting siRNA therapies.

Contact Information

Website
www.gensaic.com
Formerly Known As
M13 Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • LabCentral 238
  • Cambridge, MA 02139
  • United States
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Big Data, Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • LabCentral 238
  • Cambridge, MA 02139
  • United States

Gensaic Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gensaic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 03-Mar-2025 Completed Generating Revenue
4. Early Stage VC 09-Jan-2023 Completed Pre-Clinical Trials
3. Accelerator/Incubator 01-Jan-2023 Completed Pre-Clinical Trials
2. Early Stage VC 06-Sep-2022 $5M $10M Completed Pre-Clinical Trials
1. Seed Round 08-Jun-2021 $5M $5M Completed Startup
To view Gensaic’s complete valuation and funding history, request access »

Gensaic Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view Gensaic’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Gensaic Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a machine-guided protein design platform designed to create tissue-selective, intracellular therapies for m
Drug Delivery
Cambridge, MA
10 As of 2025

Waltham, MA
 

Berkeley, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Gensaic Competitors (11)

One of Gensaic’s 11 competitors is Bonito Biosciences, a Venture Capital-Backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bonito Biosciences Venture Capital-Backed Waltham, MA
Nosis Bio Venture Capital-Backed Berkeley, CA
AI Proteins Venture Capital-Backed Boston, MA
Switch Therapeutics Venture Capital-Backed South San Francisco, CA
Ampersand Biomedicines Venture Capital-Backed Boston, MA
You’re viewing 5 of 11 competitors. Get the full list »

Gensaic Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gensaic Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Novo Nordisk Corporation Minority
Cystic Fibrosis Foundation Limited Partner Minority
Termeer Institute Accelerator/Incubator
Ovid Therapeutics Corporation Minority
To view Gensaic’s complete investors history, request access »

Ready to get started?

Request a free trial

Gensaic FAQs

  • When was Gensaic founded?

    Gensaic was founded in 2020.

  • Where is Gensaic headquartered?

    Gensaic is headquartered in Cambridge, MA.

  • What is the size of Gensaic?

    Gensaic has 10 total employees.

  • What industry is Gensaic in?

    Gensaic’s primary industry is Drug Delivery.

  • Is Gensaic a private or public company?

    Gensaic is a Private company.

  • What is Gensaic’s current revenue?

    The current revenue for Gensaic is .

  • How much funding has Gensaic raised over time?

    Gensaic has raised $13.5M.

  • Who are Gensaic’s investors?

    Novo Nordisk, Cystic Fibrosis Foundation, Termeer Institute, and Ovid Therapeutics have invested in Gensaic.

  • Who are Gensaic’s competitors?

    Bonito Biosciences, Nosis Bio, AI Proteins, Switch Therapeutics, and Ampersand Biomedicines are some of the 11 competitors of Gensaic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process